N-[4-(3-cyanophenyl)-5-(2,6-dimethyl-4-pyridinyl)-1,3-thiazol-2-yl]-4-sulfamoylpiperazine-1-carboxamide
C22H23N7O3S2 — CID 162688189
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-(3-cyanophenyl)-5-(2,6-dimethyl-4-pyridinyl)-1,3-thiazol-2-yl]-4-sulfamoylpiperazine-1-carboxamide
N-[4-(3-cyanophenyl)-5-(2,6-dimethyl-4-pyridinyl)-1,3-thiazol-2-yl]-4-sulfamoylpiperazine-1-carboxamide (PubChem CID 162688189) has the molecular formula C22H23N7O3S2 and a molecular weight of 497.61 g/mol. Its IUPAC name is N-[4-(3-cyanophenyl)-5-(2,6-dimethyl-4-pyridinyl)-1,3-thiazol-2-yl]-4-sulfamoylpiperazine-1-carboxamide.
Molecular Properties
| Compound Name | N-[4-(3-cyanophenyl)-5-(2,6-dimethyl-4-pyridinyl)-1,3-thiazol-2-yl]-4-sulfamoylpiperazine-1-carboxamide |
|---|---|
| PubChem CID | 162688189 |
| Molecular Formula | C22H23N7O3S2 |
| Molecular Weight | 497.61 g/mol |
| Exact Mass | 497.13 |
| IUPAC Name | N-[4-(3-cyanophenyl)-5-(2,6-dimethyl-4-pyridinyl)-1,3-thiazol-2-yl]-4-sulfamoylpiperazine-1-carboxamide |
| SMILES | Cc1cc(-c2sc(NC(=O)N3CCN(S(N)(=O)=O)CC3)nc2-c2cccc(C#N)c2)cc(C)n1 |
| InChI | InChI=1S/C22H23N7O3S2/c1-14-10-18(11-15(2)25-14)20-19(17-5-3-4-16(12-17)13-23)26-21(33-20)27-22(30)28-6-8-29(9-7-28)34(24,31)32/h3-5,10-12H,6-9H2,1-2H3,(H2,24,31,32)(H,26,27,30) |
| InChIKey | QGRMOKFVWXSTQC-UHFFFAOYSA-N |
| XLogP | 2.71 |
| TPSA | 145.31 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 497.61 |
| LogP ≤ 5 | 2.71 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162688189 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.